The safety and effectiveness of Wegovy tablets have not been established in pediatric patients Geriatric: In the CV outcomes trial, patients 75 years reported more hip and pelvis fractures on Wegovy injection than placebo
Adding GOLO, which lacks comparable evidence, is unlikely to enhance results and may complicate the assessment of treatment response
When combined with lifestyle modifications like diet and exercise, these treatments offer effective and safe options to achieve significant weight loss, making them valuable tools in modern wellness and weight management strategies
Appetite returned, and metabolic benefits like improved insulin sensitivity began to decline over time
Its ~1-week half-life is the reason weekly dosing works
The SELECT cardiovascular outcomes trial (N=17,604), published in NEJM 2023 (DOI: 10.1056/NEJMoa2307563), demonstrated a 20% reduction in major adverse cardiovascular events (MACE) -- the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke -- in overweight or obese adults without diabetes
